Represented one of the world’s largest pharmaceutical companies in the trial of a Hatch-Waxman case relating to the drug cinacalcet hydrochloride, which has an annual domestic market in excess of $400 million.

Brigham and Women's Hospital Inc., et al v. Teva Pharmaceuticals USA Inc. et al., No. 08-464 (D. Del. filed July 25, 2008).

Experience Center

Match our Experience to Your Needs

Experience Highlights

International arbitration counsel for multinational consumer products corporation in major insurance recovery actions
The firm served as lead counsel in representing a major multinational corporation headquartered in Switzerland in two related international more
Multiple financings by Provident Bankshares Corporation
Represented Provident Bankshares Corporation in its $64.8 million private placement of convertible preferred stock and common stock and a $50 million more
Proxy contest for Emageon Inc.
Represented Emageon Inc., a publicly traded medical image software developer, in connection with a hostile proxy contest by Oliver Press Partners, more
Acquisition of landmark building project
Represented a major German asset management company on the acquisition of a new landmark office building project in Central Stockholm. Due to the more